Replies to post #5620 on InVivo Therapeutics Holdings Corp (NVIVQ)

[DDobserver]

No they do not. This is overpriced by three dollars per share. Intrinsic value that would justify this valuation has not been met. All that is here is a gamble. Granted, Dr. Langer and several others are top shelf, second to none, but that does not change intrinsic value.